Genetically engineered dendritic cells in cancer immunotherapy: from immune reprogramming strategies to emerging CAR-DC platforms

Farid Ghorbaninezhad; Milad Taghizadeh Anvar; Ali Abedian; Mahsa Iravani; Ahmad Ghorbani; Mina Hobbi; Negin Dadmehr; Sajjad Samadian; Elham Safarzadeh

doi:10.1038/s41698-026-01702-9

Enriched recordOpen access

Genetically engineered dendritic cells in cancer immunotherapy: from immune reprogramming strategies to emerging CAR-DC platforms

Farid Ghorbaninezhad, Milad Taghizadeh Anvar, Ali Abedian, Mahsa Iravani, Ahmad Ghorbani, Mina Hobbi, Negin Dadmehr, Sajjad Samadian, Elham Safarzadeh

npj Precision Oncology2026doi:10.1038/s41698-026-01702-9

Citation graph

Abstract

No public abstract is available from the verified source records.

Authors

Farid Ghorbaninezhad#1 Milad Taghizadeh Anvar#2 Ali Abedian#3 Mahsa Iravani#4 Ahmad Ghorbani#5 Mina Hobbi#6 Negin Dadmehr#7 Sajjad Samadian#8 Elham Safarzadeh#9

Institutions

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

No reference metadata is available yet.

External cited-by records

No external cited-by metadata is available yet.